(Q44372685)

English

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wyndham H. Wilson

3

object named as

Wyndham H Wilson

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Michael R Bishop

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jeannie Whit-Shan Hou

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Seth M Steinberg

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jeanne Odom

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kathleen Castro

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Claude Kasten-Sportes

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Juan Gea-Banacloche

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Donna Marchigiani

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ronald Gress

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Daniel H Fowler

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

162-169

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New drugs and novel targets for treatment of invasive fungal infections in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment syndrome following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18)

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(03)70005-6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44372685&oldid=2020533010"